Preferred Name | Saxagliptin Anhydrous | |
Synonyms |
Saxagliptin Anhydrous SAXAGLIPTIN ANHYDROUS |
|
Definitions |
The anhydrous form of saxagliptin, a potent, selective and competitive, cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75984 |
|
CAS_Registry |
361442-04-8 |
|
Chemical_Formula |
C18H25N3O2 |
|
code |
C75984 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
The anhydrous form of saxagliptin, a potent, selective and competitive, cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite. |
|
FDA_UNII_Code |
8I7IO46IVQ |
|
FULL_SYN |
Saxagliptin Anhydrous SAXAGLIPTIN ANHYDROUS |
|
label |
Saxagliptin Anhydrous |
|
Legacy Concept Name |
Saxagliptin_Anhydrous |
|
Preferred_Name |
Saxagliptin Anhydrous |
|
prefixIRI |
Thesaurus:C75984 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C2699273 |
|
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.obolibrary.org/obo/NCIT_C75984 | BERO | LOOM | |
http://purl.bioontology.org/ontology/RXNORM/1546030 | RXNORM | LOOM |